/
Courtesy CDC Public Health Image Library Courtesy CDC Public Health Image Library

Courtesy CDC Public Health Image Library - PowerPoint Presentation

webraph
webraph . @webraph
Follow
343 views
Uploaded On 2020-06-15

Courtesy CDC Public Health Image Library - PPT Presentation

Photograph Dr David PhillipsGetty ImagesVisuals Unlimited Courtesy CDC Public Health Image Library The Case for PrEP STD and HIV epidemiology in Santa Clara County PrEP Making HIV Prevention Easy October 2017 ID: 777331

hiv county santa department county hiv department santa health clara public 2016 std prep scc 2017 chlamydia data syphilis

Share:

Link:

Embed:

Download Presentation from below link

Download The PPT/PDF document "Courtesy CDC Public Health Image Library" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Courtesy CDC Public Health Image Library

Photograph:

Dr

David Phillips/Getty Images/Visuals Unlimited

Courtesy CDC Public Health Image Library

The Case for

PrEP: STD and HIV epidemiology in Santa Clara County

PrEP: Making HIV Prevention Easy. October, 2017

Sarah C. Lewis, MD, MPH

STD/HIV Controller & Assistant Public Health Officer

Santa Clara County Public Health Department

Slide2

Disclosure InformationSarah C. Lewis,

MD MPH

I have no financial relationships to disclose.I will discuss off label use of NAATs.

Slide3

Learning ObjectivesUnderstand local epidemiology of HIV and STDs in SCCIdentify patient populations at risk for HIV and STDs SCC based on epidemiology and screening recommendations

Recognize benefit of PrEP for prevention of other STDs

Slide4

OverviewEpidemiology of STDs in Santa Clara County Recommendations for HIV

Screening and PreventionBacterial STDs and the Power of Screening

Slide5

2016 Summary DataEpidemiology of STDs in Santa Clara County

Slide6

Pop quiz!Which of the following statements most accurately describes the current epidemiologic STD trends in Santa Clara County?

New prevention and treatment options have contributed to overall declining rates of chlamydia, gonorrhea, and syphilis in SCC and nationally.

Despite increases in surrounding counties, rates of chlamydia, gonorrhea, and syphilis are stable or falling in SCC, likely due to increased healthcare access.Surveillance reporting shows rising rates of chlamydia, gonorrhea, and syphilis, along with persistent disparities by race, ethnicity, gender, and gender of partners.Data suggest rising rates of chlamydia, gonorrhea, and syphilis in SCC, but these are most likely confounded by new testing guidelines and increased access to care.

Slide7

Pop quiz!Which of the following statements most accurately describes the current epidemiologic STD trends in Santa Clara County?

New prevention and treatment options have contributed to overall declining rates of chlamydia, gonorrhea, and syphilis in SCC and nationally.

Despite increases in surrounding counties, rates of chlamydia, gonorrhea, and syphilis are stable or falling in SCC, likely due to increased healthcare access.Surveillance reporting shows rising rates of chlamydia, gonorrhea, and syphilis, along with persistent disparities by race, ethnicity, gender, and gender of partners.Data suggest rising rates of chlamydia, gonorrhea, and syphilis in SCC, but these are most likely confounded by new testing guidelines and increased access to care.

Slide8

Chlamydia case counts and rates in Santa Clara

County, 2010-2016

Sources: 1. SCC Public Health Department, AVSS (2010-2011), CalREDIE (2011-2016), data as of March, 2017, and are provisional; 2. State of California, Department of Finance, State and County Population Projections by Race/Ethnicity and Age, 2010-2060, December 15, 2014

Slide9

Slide10

Sources: 1. SCC Public Health Department, AVSS (2010-2011),

CalREDIE

(2011-2016), data as of March, 2017, and are provisional; 2. State of California, Department of Finance, State and County Population Projections by Race/Ethnicity and Age, 2010-2060, December 15, 2014

Slide11

* Due to large proportions of missing race/ethnicity information, u

nknown race/ethnicity cases were redistributed based on the proportions of the known race/ethnicity cases with consideration of age. Rates and counts based on imputed race/ethnicity need to be interpreted with precautions.

Sources: 1. SCC Public Health Department, CalREDIE (2016), data as of March, 2017, and are provisional; 2. State of California, Department of Finance, State and County Population Projections by Race/Ethnicity and Age, 2010-2060, December 15, 2014

Slide12

* Includes primary, secondary and early latent syphilis cases.

Sources: 1. SCC Public Health Department, AVSS (2010-2011),

CalREDIE (2011-2016), data as of March, 2017, and are provisional; 2. State of California, Department of Finance, State and County Population Projections by Race/Ethnicity and Age, 2010-2060, December 15, 2014

Slide13

* Include primary, secondary and early latent syphilis cases.

Sources: 1. SCC Public Health Department, AVSS (2010-2011),

CalREDIE (2011-2016), data as of March, 2017, and are provisional; 2. State of California, Department of Finance, State and County Population Projections by Race/Ethnicity and Age, 2010-2060, December 15, 2014

Slide14

HIV epidemic in Santa Clara County

As of 2016:

Cumulative HIV/AIDS cases first reported in SCC*: 6,179

AIDS: 4,801

Alive: 3,669

People living with HIV/AIDS

: 3,208

2,648 (83%) SCC cases

560 (17%) out of jurisdiction cases

In 2016:

134 new cases

* Based on residency at diagnosis;

† Based on most current address;

Source: Santa Clara County Public Health Department, eHARS data as of May, 2017 and are provisional

Slide15

Rates of HIV/AIDS diagnoses among individuals 13+

, 2010 –

2016Source: 1. Santa Clara County Public Health Department, eHARS data as of May, 2017; 2. State of California, Department of Finance, State and County Population Projections by Race/Ethnicity and Age, 2010-2060, Sacramento, California, February 2017

Slide16

Number of MSM cases* by selected age group,

2010 – 2016

* Include MSM, MSM & IDU. Source: Santa Clara County Public Health Department, eHARS data as of May, 2017, and are provisional.

Slide17

Number of MSM cases* by race/ethnicity, 2010

– 2016

* Include MSM, MSM & IDU. Source: Santa Clara County Public Health Department, eHARS data as of May, 2017, and are provisional.

Slide18

Who were more likely to be diagnosed late*?

Older age groups (ages 40+)

44% (ages 40+) vs. 23% (ages <40)People of color37% (AA), 35% (API), 34% (Hispanic) vs. 25% (White)IDU and individuals acquiring through heterosexual transmission44% (IDU) and 45% (Heterosexual) vs. 26% (MSM) and 28% (MSM&IDU)Foreign-born42% (foreign-born) vs. 27% (U.S.-born)* Statistically significant with p < 0.05

Source: Santa Clara County Public Health Department, eHARS data as of May, 2017.

Slide19

Percentage of people living with HIV with STD

† Santa Clara County, 2016

† People ages 13 and older chlamydia, gonorrhea, early syphilis (primary, secondary and early latent) diagnosed in 2016. A person with multiple episodes of one disease in the year will be only counted once for the disease. * Include primary, secondary and early latent syphilis cases. ** The percentage of overall STD diagnosis is lower than the sum of the percentages of chlamydia, gonorrhea and early syphilis because one person may be diagnosed with multiple diseases.

Source: 1.

Santa Clara County Public Health Department, eHARS data as of May, 2017, 2. Santa Clara County Public Health Department, CalREDIE (2016), data as of March, 2017, and are provisional

Slide20

Making HIV Prevention EasyHIV Screening and Prevention

Slide21

Who should be screened for HIV?All patients ages 13 – 64 years in all health-care settings.All patients who seek evaluation and treatment for STDs.

All pregnant patients in 1st trimester; again in 3rd trimester and at delivery if at high risk.

MSM annually and up to q3 months if at high risk.NO need for separate written consent. (Opt-out)

Slide22

HIV PreventionTreatment as Prevention (TasP) depends on diagnosis and linkage

Pre-Exposure Prophylaxis:Can be provided in primary care settingsNavigation help for clients: 408-792-3750Clinical consult for providers: 855-HIV-PrEP (Monday – Friday: 8am to 3pm)

STD/HIV Controller: 408-792-5051Resources for providers: Stay Tuned!

Slide23

Rapid rise in PrEP use in the US

But lower uptake in: People of colorAfrican Americans

LatinxYouthTransgender people2014

2013

2012

2012

2013

2014

2015

~80,000

unique individuals started

PrEP

in 2012-2015

738% increase

Slide courtesy of Stephanie

E. Cohen

Slide24

% of Adults with PrEP Indication

No. of Adults with PrEP Indication

Slide courtesy of Catherine Koss & Stephanie E. Cohen

Slide25

HIV prevention in any roleScreen for HIV and risk factorsScreen for and treat bacterial STDsOffer

PrEP resources in your waiting roomRefer for PrEP Navigation: 408-792-3750

Slide26

Making HIV Prevention EasyBacterial STDs:The power of screening

Slide27

Who Should be Screened for CT/GC?

CDC 2015 STD

Tx Guidelines www.cdc.gov/std/treatmentPlus: Guidelines for HIV care and PrEP

Slide28

High Proportion of Extragenital CT/GC associated

with negative urine test

STD Surveillance Network (n=21,994)Patton et al CID 2014

Slide courtesy of Dr. Ina Park.

Slide29

A Majority of Rectal Infections in MSM are Asymptomatic

Chlamydia

n=316

Gonorrhea

n=264

Chlamydia

n=315

Gonorrhea

n=364

Rectal Infections

Urethral Infections

Asymptomatic

Symptomatic

Kent, CK et al,

Clin

Infect Dis July 2005

86%

84%

42%

10%

Slide courtesy of Dr. Ina Park.

Slide30

Chlamydia and

Gonorrhea NAAT: Rectal and Pharyngeal Sites

Commercially-available NAATs have not been cleared by FDA for these indicationsThey can be used by laboratories that have undergone validation procedures and met all regulatory requirements for an off-label procedureSimilar validation procedures apply for self-collected specimensMMWR. Mar 14 2014;63(No RR-12):1-19. Slide courtesy of Dr. Ina Park.

Slide31

Clinical Guidelines and Consultation

CDC’s STD Treatment Guidelines

www.cdc.gov/std/treatment/ STD Clinical Consult Networkwww.stdccn.org Free CDC STD Treatment Guidelines AppSearch for “STD TX”

Slide courtesy of Dr. Ina Park.

Slide32

STDs among PrEP users in

PrEP Demo

26.4% of participants had GC, CT or early syphilis at baseline50.9% had at least one STI during follow-upSTI incidence was high but did not increase over time% infections for which treatment would have been delayed with q6 month, as opposed to q3 month, screeningLiu JAMA Intern Med 2016; Cohen # 870 CROI 2016. Slide courtesy of Dr. Stephanie Cohen

Slide33

STDs among PrEP Users at SF Kaiser

Volk et al. CID 2015;

Slide courtesy Dr. Jonathan Volk and Dr. Stephanie Cohen

Slide34

Modeling Study of PrEP Impact on STI Incidence

With 40% PrEP coverage and 40% risk compensation.42% and of GC and 40% of CT infections would be averted over the next 10 years.

Jenness et al. CID, 2017.

Slide35

ConclusionsBacterial STDs are on the rise in Santa Clara and CaliforniaYoung Latino and Black MSM are at highest risk for HIV in SCC

Self-collected three-site screening can make STD testing fast and easyPrEP prevents HIV and also creates opportunities

to decrease STDs

Slide36